PDS Biotechnology Corpora... (PDSB)

AI Score

Unlock

1.06

-0.09 (-8.23%)

At close: Apr 03, 2025, 3:59 PM

1.08

1.98%

Pre-market: Apr 04, 2025, 05:43 AM EDT

PDS Biotechnology Balance Sheet Statement

Chart Mode

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014	Dec 31, 2013	Dec 31, 2012
Cash & Equivalents	41.69B	56.56M	73.82M	65.24M	28.84M	12.16M	34.65M	88.07M	106.4M	130.19M	13.73M	7.86M	140.93K
Short-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	303.91M	n/a	0.00	0.00	-0.00	-0.00	142.87K	96.06K	90.95K	55.16K	160.68K	63.93K	8.77K
Receivables	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	459.02K	n/a
Inventory	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	3.36B	2.49M	2.66M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	1.41M	n/a	6.46K
Total Current Assets	45.05B	59.06M	76.48M	66.84M	30.34M	14.47M	35.65M	89.05M	107.35M	131.27M	15.44M	8.53M	147.39K
Property-Plant & Equipment	304.21K	335K	527.53K	357.7K	553.15K	21.05K	426.95K	3.42M	3.42M	2.77M	1.44M	140.04K	7.59K
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	46.8K	51.92K	n/a	n/a	n/a	n/a
Total Long-Term Assets	304.21M	335K	527.53K	357.7K	553.15K	21.05K	569.82K	3.57M	3.56M	2.82M	1.6M	203.97K	16.36K
Total Assets	45.36B	59.39M	77.01M	67.2M	30.89M	14.49M	36.22M	92.62M	110.91M	134.09M	17.05M	8.73M	163.76K
Account Payables	1.68M	6.98M	1.22M	1.31M	1.42M	1.2M	399.45K	4.37M	3.47M	2.58M	2.05M	1.09M	n/a
Deferred Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	25K	6.84K	34.39K	-265.26K	n/a	7.49K
Short-Term Debt	12.56B	4.17M	n/a	n/a	n/a	n/a	n/a	3.08M	n/a	2.27M	265.26K	n/a	172.05K
Other Current Liabilities	2.84B	1.14M	n/a	729.39K	424.6K	498.19K	5.62M	1.91M	1.87M	2.19M	982.16K	390.99K	3.32M
Total Current Liabilities	17.09B	13.63M	9.82M	3.76M	3.27M	2.79M	6.38M	12.87M	6.68M	8.59M	3.89M	1.79M	3.52M
Long-Term Debt	9.2M	19.51M	23.02M	n/a	n/a	n/a	30K	17.38M	14.95M	3.03M	2.53M	n/a	27.14K
Other Long-Term Liabilities	9.26B	n/a	n/a	n/a	n/a	n/a	291.23K	n/a	n/a	n/a	38.46M	22.3M	n/a
Total Long-Term Liabilities	9.27B	19.63M	23.18M	231.43K	490.35K	n/a	321.23K	17.38M	14.95M	3.03M	40.99M	22.3M	27.14K
Total Liabilities	26.35B	33.26M	33.01M	3.99M	3.76M	2.79M	6.38M	30.25M	21.64M	11.62M	44.88M	24.08M	3.55M
Total Debt	12.62B	23.85M	23.47M	490.35K	610.26K	n/a	30K	20.46M	14.95M	5.3M	2.79M	n/a	199.19K
Common Stock	12.54K	10.92K	9.96K	9.39K	7.35K	1.74K	10.59K	10.4K	9.76K	9.72K	770.00	770.00	770.00
Retained Earnings	-182.11B	-144.5M	-101.56M	-60.7M	-43.79M	-28.94M	-192.82M	-151.95M	-101.07M	-62.25M	-29.82M	-16.04M	-8.08M
Comprehensive Income	n/a	n/a	0.00	0.00	0.00	n/a	-451.66K	-305.28K	-122.36K	-91.39K	-38.28K	-7.05K	n/a
Shareholders Equity	19B	26.13M	44M	63.21M	27.13M	11.7M	29.84M	62.37M	89.28M	122.48M	-27.83M	-15.35M	-3.38M
Total Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a